Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver
文献类型：期刊论文
| 作者 | Xiaohan Xu6; Kyle L. Poulsen5; Lijuan Wu6; Shan Liu4; Tatsunori Miyata3; Qiaoling Song4; Qingda Wei2; Chenyang Zhao6; Chunhua Lin1; Jinbo Yang6 |
| 刊名 | Signal Transduction and Targeted Therapy
 |
| 卷号 | 7期号:1 |
| ISSN号 | 2059-3635 |
| 英文摘要 | Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive and more susceptible to developing cirrhosis and hepatocellular carcinoma. Currently, lifestyle interventions are the most essential and effective strategies for preventing and controlling NAFL without the development of fibrosis. While there are still limited appropriate drugs specifically to treat NAFL/NASH, growing progress is being seen in elucidating the pathogenesis and identifying therapeutic targets. In this review, we discussed recent developments in etiology and prospective therapeutic targets, as well as pharmacological candidates in pre/clinical trials and patents, with a focus on diabetes, hepatic lipid metabolism, inflammation, and fibrosis. Importantly, growing evidence elucidates that the disruption of the gut–liver axis and microbe-derived metabolites drive the pathogenesis of NAFL/NASH. Extracellular vesicles (EVs) act as a signaling mediator, resulting in lipid accumulation, macrophage and hepatic stellate cell activation, further promoting inflammation and liver fibrosis progression during the development of NAFL/NASH. Targeting gut microbiota or EVs may serve as new strategies for the treatment of NAFL/NASH. Finally, other mechanisms, such as cell therapy and genetic approaches, also have enormous therapeutic potential. Incorporating drugs with different mechanisms and personalized medicine may improve the efficacy to better benefit patients with NAFL/NASH. |
| 语种 | 英语 |
| 源URL | [http://ir.yic.ac.cn/handle/133337/32022]  |
| 专题 | 烟台海岸带研究所_中科院烟台海岸带研究所知识产出 |
| 作者单位 | 1.中国科学院烟台海岸带研究所 2.郑州大学 3.熊本大学 4.黑龙江省环境保护科学研究院 5.University of Texas Health Science Center 6.中国海洋大学 |
| 推荐引用方式 GB/T 7714 | Xiaohan Xu,Kyle L. Poulsen,Lijuan Wu,et al. Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver[J]. Signal Transduction and Targeted Therapy,7(1). |
| APA | Xiaohan Xu.,Kyle L. Poulsen.,Lijuan Wu.,Shan Liu.,Tatsunori Miyata.,...&Jinbo Yang. |
| MLA | Xiaohan Xu,et al."Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver".Signal Transduction and Targeted Therapy 7.1 |
入库方式： OAI收割
来源：烟台海岸带研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。